3sg9

From Proteopedia
Revision as of 10:55, 29 June 2022 by OCA (talk | contribs)
Jump to navigation Jump to search

Crystal Structure of Aminoglycoside-2-Phosphotransferase Type IVa Kanamycin A ComplexCrystal Structure of Aminoglycoside-2-Phosphotransferase Type IVa Kanamycin A Complex

Structural highlights

3sg9 is a 2 chain structure with sequence from "streptococcus_casseliflavus"_vaughan_et_al._1979 "streptococcus casseliflavus" vaughan et al. 1979. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Ligands:,
Gene:aph(2)-Id ("Streptococcus casseliflavus" Vaughan et al. 1979)
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Publication Abstract from PubMed

Aminoglycoside 2-phosphotransferase IVa [APH(2)-IVa] is a member of a family of bacterial enzymes responsible for medically relevant resistance to antibiotics. APH(2)-IVa confers high-level resistance against several clinically used aminoglycoside antibiotics in various pathogenic Enterococcus species by phosphorylating the drug, thereby preventing it from binding to its ribosomal target and producing a bactericidal effect. We describe here three crystal structures of APH(2)-IVa, one in its apo form and two in complex with a bound antibiotic, tobramycin and kanamycin A. The apo structure was refined to a resolution of 2.05 A, and the APH(2)-IVa structures with tobramycin and kanamycin A bound were refined to resolutions of 1.80 and 2.15 A, respectively. Comparison among the structures provides insight concerning the substrate selectivity of this enzyme. In particular, conformational changes upon substrate binding, involving rotational shifts of two distinct segments of the enzyme, are observed. These substrate-induced shifts may also rationalize the altered substrate preference of APH(2)-IVa in comparison to those of other members of the APH(2) subfamily, which are structurally closely related. Finally, analysis of the interactions between the enzyme and aminoglycoside reveals a distinct binding mode as compared to the intended ribosomal target. The differences in the pattern of interactions can be utilized as a structural basis for the development of improved aminoglycosides that are not susceptible to these resistance factors.

Crystal Structures of Antibiotic-Bound Complexes of Aminoglycoside 2-Phosphotransferase IVa Highlight the Diversity in Substrate Binding Modes among Aminoglycoside Kinases.,Shi K, Houston DR, Berghuis AM Biochemistry. 2011 Jun 27. PMID:21678960[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

See Also

References

  1. Shi K, Houston DR, Berghuis AM. Crystal Structures of Antibiotic-Bound Complexes of Aminoglycoside 2-Phosphotransferase IVa Highlight the Diversity in Substrate Binding Modes among Aminoglycoside Kinases. Biochemistry. 2011 Jun 27. PMID:21678960 doi:10.1021/bi200747f

3sg9, resolution 2.15Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA